CHU Tours - Hôpital Trousseau

Chambray-lès-Tours, Indre Et Loire 37170

0 studies enrolling now · 2 studies all time

What they study most

Dyslipidemia, Type2 Diabetes, Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction

Studies at this site

• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100) — Completed